The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...
A 16-week trial involving children with type 1 diabetes (T1D) found glucose level was in the target range for a greater percentage of time in individuals who used a closed-loop system compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results